$SEM
SELECT MEDICAL HOLDINGS CORP Stock $sem

$sem Overview Financials Valuation SEC Filings Company Website

2019 Form 10-K Financial Statement

#000162828020001905 Filed on February 20, 2020

Income Statement

Concept	2019	2018 Q4	2018 Q3
Revenue	$5.454B	$1.265B	$1.267B
YoY Change	7.33%	13.49%	17.68%
Cost Of Revenue	$4.641B	$1.094B	$1.087B
YoY Change	6.91%	15.48%	15.76%
Gross Profit	$812.9M	$171.2M	$180.3M
YoY Change	9.82%	16.15%	30.74%
Gross Profit Margin	14.9%	13.54%	14.23%
Selling, General & Admin	$128.5M	$30.30M	$30.00M
YoY Change	5.94%	-0.98%	10.7%
% of Gross Profit	15.81%	17.7%	16.64%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$182.9M	$52.70M	$50.50M
YoY Change	6.52%	30.45%	30.49%
% of Gross Profit	22.5%	30.78%	28.0%
Operating Expenses	$341.0M	$82.90M	$80.40M
YoY Change	5.61%	16.76%	22.19%
Operating Profit	$471.9M	$88.28M	$99.84M
YoY Change	13.09%	15.63%	38.47%
Interest Expense	$200.6M	-$43.50M	$50.67M
YoY Change	1.05%	31.42%	-252.16%
% of Operating Profit	42.5%	-49.27%	50.75%
Other Income/Expense, Net
YoY Change
Pretax Income	$264.7M	$40.90M	$56.74M
YoY Change	12.4%	-5.54%	46.08%
Income Tax	$63.72M	$11.20M	$14.06M
% Of Pretax Income	24.07%	27.38%	24.78%
Net Earnings	$148.4M	$24.67M	$32.92M
YoY Change	7.7%	-75.52%	78.3%
Net Earnings / Revenue	2.72%	1.95%	2.6%
Basic Earnings Per Share	$1.10	$0.18	$0.24
Diluted Earnings Per Share	$1.10	$0.18	$0.24
COMMON SHARES
Basic Shares Outstanding	130.2M shares	135.3M shares	130.4M shares
Diluted Shares Outstanding	130.3M shares		130.4M shares

Balance Sheet

Concept	2019	2018 Q4	2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$335.9M	$175.2M	$160.4M
YoY Change	91.72%	43.02%	49.49%
Cash & Equivalents	$335.9M	$175.2M	$160.4M
Short-Term Investments
Other Short-Term Assets	$114.4M	$90.13M	$96.21M
YoY Change	3.44%	19.92%	19.82%
Inventory
Prepaid Expenses
Receivables	$762.7M	$706.7M	$746.8M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.213B	$992.5M	$1.023B
YoY Change	22.22%	7.79%	13.18%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.002B	$979.8M	$965.4M
YoY Change	104.37%	7.37%	2.04%
Goodwill		$3.321B	$3.311B
YoY Change		19.33%
Intangibles		$437.7M	$444.8M
YoY Change		34.05%
Long-Term Investments	$146.9M
YoY Change	-36.32%
Other Assets	$177.0M	$233.5M	$235.2M
YoY Change	6221.43%	26.62%	34.55%
Total Long-Term Assets	$6.127B	$4.972B	$4.957B
YoY Change	23.24%	18.2%	17.47%
TOTAL ASSETS
Total Short-Term Assets	$1.213B	$992.5M	$1.023B
Total Long-Term Assets	$6.127B	$4.972B	$4.957B
Total Assets	$7.340B	$5.964B	$5.980B
YoY Change	23.07%	16.33%	16.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$145.7M	$146.7M	$137.5M
YoY Change	-0.68%	14.43%	3.18%
Accrued Expenses	$740.7M	$485.9M	$494.0M
YoY Change	52.44%	16.66%	22.58%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$25.10M	$23.30M
YoY Change	-100.0%	-14.92%	23.28%
Long-Term Debt Due	$25.20M	$43.90M	$24.20M
YoY Change	-42.6%	97.75%	-35.64%
Total Short-Term Liabilities	$914.3M	$705.2M	$685.1M
YoY Change	29.65%	16.48%	14.28%
LONG-TERM LIABILITIES
Long-Term Debt	$3.420B	$3.250B	$3.306B
YoY Change	5.24%	21.35%	20.08%
Other Long-Term Liabilities	$954.2M	$158.9M	$174.2M
YoY Change	500.5%	9.08%	26.12%
Total Long-Term Liabilities	$4.374B	$158.9M	$174.2M
YoY Change	28.33%	9.08%	-93.98%
TOTAL LIABILITIES
Total Short-Term Liabilities	$914.3M	$705.2M	$685.1M
Total Long-Term Liabilities	$4.374B	$158.9M	$174.2M
Total Liabilities	$6.569B	$4.268B	$4.313B
YoY Change	27.28%	20.09%	-2.03%
SHAREHOLDERS EQUITY
Retained Earnings		$320.4M	$296.6M
YoY Change		-10.95%
Common Stock		$482.7M	$478.0M
YoY Change		4.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$771.0M	$803.0M	$774.6M
YoY Change
Total Liabilities & Shareholders Equity	$7.340B	$5.964B	$5.980B
YoY Change	23.07%	16.33%	16.71%

Cashflow Statement

Concept	2019	2018 Q4	2018 Q3
OPERATING ACTIVITIES
Net Income	$148.4M	$24.67M	$32.92M
YoY Change	7.7%	-75.52%	78.3%
Depreciation, Depletion And Amortization	$182.9M	$52.70M	$50.50M
YoY Change	6.52%	30.45%	30.49%
Cash From Operating Activities	$445.2M	$113.2M	$164.0M
YoY Change	-9.92%	4.72%	82.83%
INVESTING ACTIVITIES
Capital Expenditures	-$157.1M	-$46.30M	-$39.40M
YoY Change	-6.1%	-22.05%	-42.48%
Acquisitions	$93.71M
YoY Change	-82.09%
Other Investing Activities	-$159.6M	-$4.400M	-$11.20M
YoY Change	-69.88%	-112.05%	366.67%
Cash From Investing Activities	-$316.7M	-$50.60M	-$50.50M
YoY Change	-54.57%	120.0%	-28.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$32.25M	-47.80M	-94.10M
YoY Change	-87.38%	-31.62%	-740.14%
NET CHANGE
Cash From Operating Activities	$445.2M	113.2M	164.0M
Cash From Investing Activities	-$316.7M	-50.60M	-50.50M
Cash From Financing Activities	$32.25M	-47.80M	-94.10M
Net Change In Cash	$160.7M	14.80M	19.40M
YoY Change	205.35%	-2.63%	-42.09%
FREE CASH FLOW
Cash From Operating Activities	$445.2M	$113.2M	$164.0M
Capital Expenditures	-$157.1M	-$46.30M	-$39.40M
Free Cash Flow	$602.3M	$159.5M	$203.4M
YoY Change	-8.95%	-4.78%	28.57%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017	us-gaap	Earnings Per Share Basic Distributed EarningsPerShareBasicDistributed	0
CY2019	dei	Amendment Flag AmendmentFlag	false
CY2019	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2019	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019	dei	Entity Central Index Key EntityCentralIndexKey	0001320414
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000	shares
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.33
CY2017	us-gaap	Earnings Per Share Diluted Distributed EarningsPerShareDilutedDistributed	0
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	135265864	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	134328112	shares
CY2018	us-gaap	Earnings Per Share Basic Distributed EarningsPerShareBasicDistributed	0
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	135265864	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	134328112	shares
CY2018	us-gaap	Earnings Per Share Diluted Distributed EarningsPerShareDilutedDistributed	0
CY2019	us-gaap	Earnings Per Share Diluted Distributed EarningsPerShareDilutedDistributed	0
CY2019Q4	us-gaap	Loss Contingency Accrual Insurance Related Assessment Discount Rate LossContingencyAccrualInsuranceRelatedAssessmentDiscountRate	0.03
CY2019	dei	Document Type DocumentType	10-K
CY2019	dei	Document Annual Report DocumentAnnualReport	true
CY2019	dei	Document Period End Date DocumentPeriodEndDate	2019-12-31
CY2019	dei	Document Transition Report DocumentTransitionReport	false
CY2019	dei	Entity File Number EntityFileNumber	001-34465
CY2019	dei	Entity Registrant Name EntityRegistrantName	SELECT MEDICAL HOLDINGS CORP
CY2019	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2019	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-1764048
CY2019	dei	Entity Address Address Line1 EntityAddressAddressLine1	4714 Gettysburg Road
CY2019	dei	Entity Address Address Line2 EntityAddressAddressLine2	P.O. Box 2034
CY2019	dei	Entity Address City Or Town EntityAddressCityOrTown	Mechanicsburg
CY2019	dei	Entity Address State Or Province EntityAddressStateOrProvince	PA
CY2019	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	17055
CY2019	dei	City Area Code CityAreaCode	717
CY2019	dei	Local Phone Number LocalPhoneNumber	972-1100
CY2019	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value per share
CY2019	dei	Trading Symbol TradingSymbol	SEM
CY2019	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2019	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2019	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2019	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2019	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2019	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2019	dei	Entity Small Business EntitySmallBusiness	false
CY2019	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019	dei	Entity Shell Company EntityShellCompany	false
CY2019Q2	dei	Entity Public Float EntityPublicFloat	1704659609	USD
CY2020Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	134313112	shares
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	175178000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	335882000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	706676000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	762677000	USD
CY2018Q4	us-gaap	Prepaid Taxes PrepaidTaxes	20539000	USD
CY2019Q4	us-gaap	Prepaid Taxes PrepaidTaxes	18585000	USD
CY2018Q4	us-gaap	Other Assets Current OtherAssetsCurrent	90131000	USD
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	95848000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	992524000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	1212992000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1003986000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	979810000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	998406000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	3320726000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	3391955000	USD
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	437693000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	409068000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	233512000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	323881000	USD
CY2018Q4	us-gaap	Assets Assets	5964265000	USD
CY2019Q4	us-gaap	Assets Assets	7340288000	USD
CY2018Q4	sem	Book Overdrafts BookOverdrafts	25083000	USD
CY2019Q4	sem	Book Overdrafts BookOverdrafts	0	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	207950000	USD
CY2018Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	43865000	USD
CY2019Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	25167000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	146693000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	145731000	USD
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	172386000	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	183754000	USD
CY2018Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	110660000	USD
CY2019Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	124111000	USD
CY2018Q4	us-gaap	Interest Payable Current InterestPayableCurrent	12137000	USD
CY2019Q4	us-gaap	Interest Payable Current InterestPayableCurrent	33853000	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	190691000	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	191076000	USD
CY2018Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	3671000	USD
CY2019Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	2638000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	705186000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	914280000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	852897000	USD
CY2018Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	3249516000	USD
CY2019Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	3419943000	USD
CY2018Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	153895000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	148258000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	158940000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	101334000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	4267537000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	5436712000	USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	780488000	USD
CY2019Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	974541000	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	135000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	134000	USD
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	482556000	USD
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	491038000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	320351000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	279800000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	803042000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	770972000	USD
CY2018Q4	us-gaap	Minority Interest MinorityInterest	113198000	USD
CY2019Q4	us-gaap	Minority Interest MinorityInterest	158063000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	916240000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	929035000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5964265000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7340288000	USD
CY2017	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4365245000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5081258000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5453922000	USD
CY2017	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	3735309000	USD
CY2018	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	4341056000	USD
CY2019	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	4641002000	USD
CY2017	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	114047000	USD
CY2018	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	121268000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	128463000	USD
CY2017	us-gaap	Depreciation And Amortization DepreciationAndAmortization	160011000	USD
CY2018	us-gaap	Depreciation And Amortization DepreciationAndAmortization	201655000	USD
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	212576000	USD
CY2017	us-gaap	Costs And Expenses CostsAndExpenses	4009367000	USD
CY2018	us-gaap	Costs And Expenses CostsAndExpenses	4663979000	USD
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	4982041000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	355878000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	417279000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	471881000	USD
CY2017	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-19719000	USD
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-14155000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-38083000	USD
CY2017	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	5286000	USD
CY2017	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	21054000	USD
CY2018	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	21905000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	24989000	USD
CY2017	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-49000	USD
CY2018	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	9016000	USD
CY2019	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	6532000	USD
CY2017	us-gaap	Interest Expense InterestExpense	154703000	USD
CY2018	us-gaap	Interest Expense InterestExpense	198493000	USD
CY2019	us-gaap	Interest Expense InterestExpense	200570000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	202461000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	235552000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	264749000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-18184000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	58610000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	63718000	USD
CY2017	us-gaap	Profit Loss ProfitLoss	220645000	USD
CY2018	us-gaap	Profit Loss ProfitLoss	176942000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	201031000	USD
CY2017	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	43461000	USD
CY2018	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	39102000	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	52582000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	177184000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	137840000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	148449000	USD
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.33
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.02
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.10
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.33
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.02
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.10
CY2016Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	422159000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	905901000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	177184000	USD
CY2017	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	35639000	USD
CY2017	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	-7822000	USD
CY2017	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2017	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	18291000	USD
CY2017	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	4753000	USD
CY2017	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	-187506000	USD
CY2017	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	187506000	USD
CY2017	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2017000	USD
CY2017	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	18280000	USD
CY2017	sem	Temporary Equity Distributions To Non Controlling Interests TemporaryEquityDistributionsToNonControllingInterests	5334000	USD
CY2017	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	848000	USD
CY2017	us-gaap	Stockholders Equity Other StockholdersEquityOther	-654000	USD
CY2017Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	640818000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	932604000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	137840000	USD
CY2018	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	27775000	USD
CY2018	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	-11327000	USD
CY2018	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2018	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	20443000	USD
CY2018	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	6837000	USD
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1722000	USD
CY2018	sem	Temporary Equity Exchange Of Equity Interest TemporaryEquityExchangeOfEquityInterest	163659000	USD
CY2018	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	77815000	USD
CY2018	sem	Temporary Equity Distributions To Non Controlling Interests TemporaryEquityDistributionsToNonControllingInterests	217570000	USD
CY2018	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	95388000	USD
CY2018	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	164476000	USD
CY2018	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	-164476000	USD
CY2018	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	1330000	USD
CY2018	us-gaap	Stockholders Equity Other StockholdersEquityOther	-1190000	USD
CY2018Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	780488000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	916240000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	148449000	USD
CY2019	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	25956000	USD
CY2019	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	-26626000	USD
CY2019	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2019	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	23382000	USD
CY2019	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	38531000	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	964000	USD
CY2019	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	38121000	USD
CY2019	sem	Temporary Equity Distributions To Non Controlling Interests TemporaryEquityDistributionsToNonControllingInterests	6205000	USD
CY2019	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	14861000	USD
CY2019	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	172915000	USD
CY2019	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	-172915000	USD
CY2019	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	1387000	USD
CY2019	us-gaap	Stockholders Equity Other StockholdersEquityOther	-1560000	USD
CY2019Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	974541000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	929035000	USD
CY2017	us-gaap	Profit Loss ProfitLoss	220645000	USD
CY2018	us-gaap	Profit Loss ProfitLoss	176942000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	201031000	USD
CY2017	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	20006000	USD
CY2018	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	15721000	USD
CY2019	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	20222000	USD
CY2017	us-gaap	Depreciation And Amortization DepreciationAndAmortization	160011000	USD
CY2018	us-gaap	Depreciation And Amortization DepreciationAndAmortization	201655000	USD
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	212576000	USD
CY2017	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1133000	USD
CY2018	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-103000	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3038000	USD
CY2017	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	21054000	USD
CY2018	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	21905000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	24989000	USD
CY2017	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	6527000	USD
CY2018	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	2999000	USD
CY2019	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	22130000	USD
CY2017	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	10349000	USD
CY2018	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	9168000	USD
CY2019	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	6321000	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	19284000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	23326000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	26451000	USD
CY2017	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	11130000	USD
CY2018	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	13112000	USD
CY2019	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	11566000	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-72324000	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	7217000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-7435000	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	118833000	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-54575000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	57991000	USD
CY2017	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-1597000	USD
CY2018	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	4152000	USD
CY2019	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	4259000	USD
CY2017	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	886000	USD
CY2018	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-7857000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-6122000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3903000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1778000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5743000	USD
CY2017	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	17341000	USD
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	310000	USD
CY2018	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	27896000	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	37298000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	238131000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	494194000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	445182000	USD
CY2017	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	27390000	USD
CY2018	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	523134000	USD
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	93705000	USD
CY2017	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	233243000	USD
CY2018	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	167281000	USD
CY2019	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	157126000	USD
CY2017	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	12682000	USD
CY2018	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	13482000	USD
CY2019	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	66090000	USD
CY2017	us-gaap	Proceeds From Sales Of Business Affiliate And Productive Assets ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets	80350000	USD
CY2018	us-gaap	Proceeds From Sales Of Business Affiliate And Productive Assets ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets	6760000	USD
CY2019	us-gaap	Proceeds From Sales Of Business Affiliate And Productive Assets ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets	192000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-192965000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-697137000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-316729000	USD
CY2017	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	970000000	USD
CY2018	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	595000000	USD
CY2019	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	700000000	USD
CY2017	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	960000000	USD
CY2018	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	805000000	USD
CY2019	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	720000000	USD
CY2017	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	1139487000	USD
CY2018	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	779823000	USD
CY2019	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	1208106000	USD
CY2017	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	1179442000	USD
CY2018	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	11500000	USD
CY2019	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	1618170000	USD
CY2017	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	0	USD
CY2018	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	0	USD
CY2019	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	1244987000	USD
CY2017	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	0	USD
CY2018	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	0	USD
CY2019	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	710000000	USD
CY2017	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	4392000	USD
CY2018	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1639000	USD
CY2018	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	29134000	USD
CY2017	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	46621000	USD
CY2018	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	42218000	USD
CY2019	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	24225000	USD
CY2017	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	20647000	USD
CY2018	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	25242000	USD
CY2019	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	30604000	USD
CY2017	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	4753000	USD
CY2018	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	6837000	USD
CY2019	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	38531000	USD
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2017000	USD
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1722000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	964000	USD
CY2017	us-gaap	Increase Decrease In Book Overdrafts IncreaseDecreaseInBookOverdrafts	-9899000	USD
CY2018	us-gaap	Increase Decrease In Book Overdrafts IncreaseDecreaseInBookOverdrafts	-4380000	USD
CY2019	us-gaap	Increase Decrease In Book Overdrafts IncreaseDecreaseInBookOverdrafts	-25083000	USD
CY2017	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	9982000	USD
CY2018	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	2926000	USD
CY2019	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	18447000	USD
CY2017	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	10620000	USD
CY2018	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	311519000	USD
CY2019	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	21780000	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-21646000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	255572000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	32251000	USD
CY2017	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	23520000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	52629000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	160704000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99029000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	122549000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	175178000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	122549000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	175178000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	335882000	USD
CY2017	us-gaap	Interest Paid Net InterestPaidNet	149156000	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	193406000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	182992000	USD
CY2017	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	64991000	USD
CY2018	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	48153000	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	70592000	USD
CY2017	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	30043000	USD
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	28760000	USD
CY2019Q4	us-gaap	Variable Interest Entity Consolidated Carrying Amount Assets VariableInterestEntityConsolidatedCarryingAmountAssets	178400000	USD
CY2018Q4	us-gaap	Variable Interest Entity Consolidated Carrying Amount Liabilities VariableInterestEntityConsolidatedCarryingAmountLiabilities	164400000	USD
CY2019Q4	us-gaap	Variable Interest Entity Consolidated Carrying Amount Liabilities VariableInterestEntityConsolidatedCarryingAmountLiabilities	176700000	USD
CY2017Q4	us-gaap	Business Acquisition Equity Interest Issued Or Issuable Value Assigned BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned	0	USD
CY2018Q4	us-gaap	Business Acquisition Equity Interest Issued Or Issuable Value Assigned BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned	238000000	USD
CY2019Q4	us-gaap	Business Acquisition Equity Interest Issued Or Issuable Value Assigned BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned	0	USD
CY2019Q4	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	47	state
CY2019	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	business_segment
CY2019	us-gaap	Use Of Estimates UseOfEstimates	<div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</span></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:justify;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, including disclosure of contingencies, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates and assumptions are used for, but not limited to: amounts realizable for services performed, estimated useful lives of assets, the valuation of intangible assets, amounts payable for self-insured losses, and the computation of income taxes. Future events and their effects cannot be predicted with certainty; accordingly, the Company’s accounting estimates require the exercise of judgment. The accounting estimates used in the preparation of the financial statements will change as new events occur, as more experience is acquired, as additional information is obtained, and as the Company’s operating environment changes. The Company’s management evaluates and updates assumptions and estimates on an ongoing basis. Actual results could differ from those estimates.</span></div>
CY2019	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Credit Risk and Payor Concentrations</span></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash balances and accounts receivable. The Company’s excess cash is held with large financial institutions. The Company grants unsecured credit to its patients, most of whom reside in the service area of the Company’s facilities and are insured under third-party payor agreements. </span></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts receivable from the Medicare program represents the only significant third-party payor concentration for the Company. The Company does not believe there is significant credit risk associated with this governmental program. Medicare receivables comprise approximately </span><span style="font-family:inherit;font-size:10pt;"><span>16%</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>15%</span></span><span style="font-family:inherit;font-size:10pt;"> of the Company’s accounts receivable at December 31, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, respectively. </span></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company’s primary collection risks for its accounts receivable relate to non-governmental payors who insure the Company’s patients and deductibles, co-payments, and self-insured amounts owed by the patient. The Company believes its credit risk with its non-governmental payors is limited due to the diversity in the Company’s non-governmental third-party payor base, as well as their geographic dispersion. Further, deductibles, co-payments, and self-insured amounts owed by the patient are an immaterial portion of the Company’s accounts receivable balance at both </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">. The Company’s general policy is to verify insurance coverage prior to the date of admission for patients admitted to its critical illness recovery hospitals and rehabilitation hospitals. Within the Company’s outpatient rehabilitation clinics, insurance coverage is verified prior to the patient’s visit. Within the Company’s Concentra centers, insurance coverage is verified or an authorization is received from the patient’s employer prior to the patient’s visit. </span></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net operating revenues generated directly from the Medicare program represented approximately </span><span style="font-family:inherit;font-size:10pt;"><span>30%</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>27%</span></span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;"><span>26%</span></span><span style="font-family:inherit;font-size:10pt;"> of the Company’s total net operating revenues for the years ended December 31, </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, respectively. As a provider of services under the Medicare program, the Company is subject to extensive regulations. The inability of any of the Company’s critical illness recovery hospitals, rehabilitation hospitals, or outpatient rehabilitation clinics to comply with Medicare regulations can result in the Company receiving significantly less Medicare payments than the Company currently receives for its services provided to patients. </span></div>
CY2017	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	4903612000	USD
CY2018	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	5128838000	USD
CY2017	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	170689000	USD
CY2018	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	140488000	USD
CY2018Q4	us-gaap	Variable Interest Entity Consolidated Carrying Amount Assets VariableInterestEntityConsolidatedCarryingAmountAssets	166200000	USD
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	277297000	USD
CY2019	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	258000	USD
CY2019	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	812000	USD
CY2019	us-gaap	Short Term Lease Cost ShortTermLeaseCost	2171000	USD
CY2019	us-gaap	Variable Lease Cost VariableLeaseCost	43649000	USD
CY2019	us-gaap	Sublease Income SubleaseIncome	9822000	USD
CY2019	us-gaap	Lease Cost LeaseCost	314365000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	274095000	USD
CY2019	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	777000	USD
CY2019	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	225000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1275575000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	9102000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1003986000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	207950000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	852897000	USD
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1060847000	USD
CY2019Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	4965000	USD
CY2019Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	195000	USD
CY2019Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	13088000	USD
CY2019Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	13283000	USD
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y
CY2019Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P34Y4M24D
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.059
CY2019Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.073
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	263085000	USD
CY2019Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	1182000	USD
CY2019Q4	sem	Lease Liability Payments Due Next Twelve Months LeaseLiabilityPaymentsDueNextTwelveMonths	264267000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	227202000	USD
CY2019Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	1193000	USD
CY2019Q4	sem	Lease Liability Payments Due Year Two LeaseLiabilityPaymentsDueYearTwo	228395000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	187053000	USD
CY2019Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	1203000	USD
CY2019Q4	sem	Lease Liability Payments Due Year Three LeaseLiabilityPaymentsDueYearThree	188256000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	143878000	USD
CY2019Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	1214000	USD
CY2019Q4	sem	Lease Liability Payments Due Year Four LeaseLiabilityPaymentsDueYearFour	145092000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	110835000	USD
CY2019Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	1225000	USD
CY2019Q4	sem	Lease Liability Payments Due Year Five LeaseLiabilityPaymentsDueYearFive	112060000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	483162000	USD
CY2019Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	30404000	USD
CY2019Q4	sem	Lease Liability Payments Due After Year Five LeaseLiabilityPaymentsDueAfterYearFive	513566000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1415215000	USD
CY2019Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	36421000	USD
CY2019Q4	sem	Lease Liability Payments Due LeaseLiabilityPaymentsDue	1451636000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	354368000	USD
CY2019Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	23138000	USD
CY2019Q4	sem	Lease Liability Undiscounted Excess Amount LeaseLiabilityUndiscountedExcessAmount	377506000	USD
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1060847000	USD
CY2019Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	13283000	USD
CY2019Q4	sem	Lease Liability LeaseLiability	1074130000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	267846000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	231711000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	193155000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	150155000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	107759000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	484038000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1434664000	USD
CY2017	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	267400000	USD
CY2018	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	307800000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1744391000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1915701000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	764581000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	917295000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	979810000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	998406000	USD
CY2017	us-gaap	Depreciation Depreciation	142600000	USD
CY2018	us-gaap	Depreciation Depreciation	171700000	USD
CY2019	us-gaap	Depreciation Depreciation	182900000	USD
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Assets EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets	125435000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	2782812000	USD
CY2018	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	542851000	USD
CY2018	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	4472000	USD
CY2018	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	9409000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	3320726000	USD
CY2019	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	78672000	USD
CY2019	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-1814000	USD
CY2019	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	5629000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	3391955000	USD
CY2018Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	516392000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	78699000	USD
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	437693000	USD
CY2019Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	510216000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	101148000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	409068000	USD
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17400000	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	29900000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	29600000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	26943000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	26624000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	26295000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	26019000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	18057000	USD
CY2017	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	178100000	USD
CY2018	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	216900000	USD
CY2019	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	308200000	USD
CY2018Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	15100000	USD
CY2019Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	31200000	USD
CY2019Q4	us-gaap	Long Term Debt LongTermDebt	3445110000	USD
CY2019Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Assets EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets	178674000	USD
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Assets EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets	118270000	USD
CY2019Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Assets EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets	317332000	USD
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	243705000	USD
CY2019Q4	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	496006000	USD
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Liabilities EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities	43792000	USD
CY2019Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Liabilities EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities	107400000	USD
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Liabilities EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities	16338000	USD
CY2019Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Liabilities EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities	127976000	USD
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Equity EquityMethodInvestmentSummarizedFinancialInformationEquity	183575000	USD
CY2019Q4	us-gaap	Equity Method Investment Summarized Financial Information Equity EquityMethodInvestmentSummarizedFinancialInformationEquity	260630000	USD
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities And Equity EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity	243705000	USD
CY2019Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities And Equity EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity	496006000	USD
CY2017	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	336349000	USD
CY2018	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	393034000	USD
CY2019	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	536464000	USD
CY2017	sem	Equity Method Investment Summarized Financial Information Cost Of Services And Other Operating Expenses EquityMethodInvestmentSummarizedFinancialInformationCostOfServicesAndOtherOperatingExpenses	289224000	USD
CY2018	sem	Equity Method Investment Summarized Financial Information Cost Of Services And Other Operating Expenses EquityMethodInvestmentSummarizedFinancialInformationCostOfServicesAndOtherOperatingExpenses	342603000	USD
CY2019	sem	Equity Method Investment Summarized Financial Information Cost Of Services And Other Operating Expenses EquityMethodInvestmentSummarizedFinancialInformationCostOfServicesAndOtherOperatingExpenses	476182000	USD
CY2017	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	45648000	USD
CY2018	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	48535000	USD
CY2019	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	58519000	USD
CY2018Q4	us-gaap	Loss Contingency Accrual Insurance Related Assessment Discount Rate LossContingencyAccrualInsuranceRelatedAssessmentDiscountRate	0.03
CY2018Q4	us-gaap	Loss Contingency Discounted Amount Of Insurance Related Assessment Liability LossContingencyDiscountedAmountOfInsuranceRelatedAssessmentLiability	175200000	USD
CY2019Q4	us-gaap	Loss Contingency Discounted Amount Of Insurance Related Assessment Liability LossContingencyDiscountedAmountOfInsuranceRelatedAssessmentLiability	157100000	USD
CY2018	us-gaap	Loss Contingency Undiscounted Amount Of Insurance Related Assessment Liability LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability	180700000	USD
CY2019	us-gaap	Loss Contingency Undiscounted Amount Of Insurance Related Assessment Liability LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability	162000000.0	USD
CY2018Q4	us-gaap	Loss Contingency Receivable LossContingencyReceivable	32400000	USD
CY2019Q4	us-gaap	Loss Contingency Receivable LossContingencyReceivable	15500000	USD
CY2019Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3447221000	USD
CY2019Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	-29577000	USD
CY2019Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	31688000	USD
CY2017	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4365245000	USD
CY2017	sem	Adjusted Ebitda AdjustedEbitda	537992000	USD
CY2019Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	3546524000	USD
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	25167000	USD
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	18405000	USD
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	29865000	USD
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	14514000	USD
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	34700000	USD
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	3324570000	USD
CY2019Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3447221000	USD
CY2018Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3338381000	USD
CY2018Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	11905000	USD
CY2018Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	33095000	USD
CY2018Q4	us-gaap	Long Term Debt LongTermDebt	3293381000	USD
CY2018Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	3222705000	USD
CY2017	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-19700000	USD
CY2017	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	6500000	USD
CY2017	sem	Gain Loss On Extinguishment Of Debt Debt Modification GainLossOnExtinguishmentOfDebtDebtModification	-13200000	USD
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-14200000	USD
CY2018	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	3000000.0	USD
CY2018	sem	Gain Loss On Extinguishment Of Debt Debt Modification GainLossOnExtinguishmentOfDebtDebtModification	-11200000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-38100000	USD
CY2019	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	22100000	USD
CY2019	sem	Gain Loss On Extinguishment Of Debt Debt Modification GainLossOnExtinguishmentOfDebtDebtModification	-16000000.0	USD
CY2017Q4	us-gaap	Assets Assets	5127166000	USD
CY2017	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	233243000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5081258000	USD
CY2018	sem	Adjusted Ebitda AdjustedEbitda	645155000	USD
CY2018Q4	us-gaap	Assets Assets	5964265000	USD
CY2018	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	167281000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5453922000	USD
CY2019	sem	Adjusted Ebitda AdjustedEbitda	710908000	USD
CY2019Q4	us-gaap	Assets Assets	7340288000	USD
CY2019	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	157126000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	355878000	USD
CY2017	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-19719000	USD
CY2017	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	21054000	USD
CY2017	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-49000	USD
CY2017	us-gaap	Interest Expense InterestExpense	154703000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	202461000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	417279000	USD
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-14155000	USD
CY2018	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	21905000	USD
CY2018	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	9016000	USD
CY2018	us-gaap	Interest Expense InterestExpense	198493000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	235552000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	471881000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-38083000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	24989000	USD
CY2019	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	6532000	USD
CY2019	us-gaap	Interest Expense InterestExpense	200570000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	264749000	USD
CY2017	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4365245000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5081258000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5453922000	USD
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	105000	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	9.18
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1600000	USD
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1800000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	700000	USD
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	19284000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	23326000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	26451000	USD
CY2019Q4	sem	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Recognizedin Year1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedRecognizedinYear1	24381000	USD
CY2019Q4	sem	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Recognizedin Year2 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedRecognizedinYear2	16031000	USD
CY2019Q4	sem	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Recognizedin Year3 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedRecognizedinYear3	8117000	USD
CY2019Q4	sem	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Recognizedin Year4 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedRecognizedinYear4	1267000	USD
CY2019Q4	sem	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Recognizedin Year5 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedRecognizedinYear5	19000	USD
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	45809000	USD
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	36072000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	55822000	USD
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	8331000	USD
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	15321000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	15331000	USD
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	54140000	USD
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	51393000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	71153000	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-72324000	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	7217000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-7435000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-18184000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	58610000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	63718000	USD
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.037
CY2018	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.050
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.042
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.017
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.021
CY2019Q4	sem	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	267513000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3271000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2344000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	131925000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.017
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.073
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.005
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.005
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	-0.006
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	-0.008
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	-0.001
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.005
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	0.021
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	0.029
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.013
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.022
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.007
CY2017	sem	Effective Income Tax Rate Reconciliation Changein Enacted Tax Rate State Percent EffectiveIncomeTaxRateReconciliationChangeinEnactedTaxRateStatePercent	-0.028
CY2018	sem	Effective Income Tax Rate Reconciliation Changein Enacted Tax Rate State Percent EffectiveIncomeTaxRateReconciliationChangeinEnactedTaxRateStatePercent	0.004
CY2019	sem	Effective Income Tax Rate Reconciliation Changein Enacted Tax Rate State Percent EffectiveIncomeTaxRateReconciliationChangeinEnactedTaxRateStatePercent	0.008
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.375
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.004
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.010
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.004
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.090
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.249
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.241
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	10313000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	13097000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	51900000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	55300000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Self Insurance DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance	13644000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Self Insurance DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance	13753000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	209000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	274000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	40163000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	38933000	USD
CY2018Q4	sem	Deferred Tax Assets Disallowed Interest Carryforwards DeferredTaxAssetsDisallowedInterestCarryforwards	4675000	USD
CY2019Q4	sem	Deferred Tax Assets Disallowed Interest Carryforwards DeferredTaxAssetsDisallowedInterestCarryforwards	4943000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	5695000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6251000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	2055000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	2914000	USD
CY2019	us-gaap	Earnings Per Share Basic Distributed EarningsPerShareBasicDistributed	0
CY2017	us-gaap	Profit Loss ProfitLoss	220645000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	405322000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17893000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	18461000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	114032000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	386861000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	13891000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	9190000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Investment In Noncontrolled Affiliates DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates	5653000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Investment In Noncontrolled Affiliates DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates	7498000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	217950000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	225079000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Financing Costs DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts	8324000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Financing Costs DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts	6250000	USD
CY2019Q4	sem	Deferred Tax Liabilities Operating Lease Rightof Use Asset DeferredTaxLiabilitiesOperatingLeaseRightofUseAsset	263818000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	3488000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	3546000	USD
CY2018Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	249306000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	515381000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	135274000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	128520000	USD
CY2018Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	18621000	USD
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	19738000	USD
CY2018Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	153895000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	148258000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	135274000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	128520000	USD
CY2018	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	4900000	USD
CY2018	sem	Valuation Allowance Deferred Tax Asset Increase Decrease Net Operating Losses Acquired In Business Combination Amount ValuationAllowanceDeferredTaxAssetIncreaseDecreaseNetOperatingLossesAcquiredInBusinessCombinationAmount	3900000	USD
CY2018	sem	Valuation Allowance Deferred Tax Asset Increase Decrease Change In State Net Operating Losses Amount ValuationAllowanceDeferredTaxAssetIncreaseDecreaseChangeInStateNetOperatingLossesAmount	1000000.0	USD
CY2019	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	600000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	135300000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	128500000	USD
CY2019	sem	Deferred Tax Asset Periodof Reviewfor Entitieswith Cumulative Losses DeferredTaxAssetPeriodofReviewforEntitieswithCumulativeLosses	P3Y
CY2018	us-gaap	Profit Loss ProfitLoss	176942000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	201031000	USD
CY2017	us-gaap	Profit Loss ProfitLoss	220645000	USD
CY2018	us-gaap	Profit Loss ProfitLoss	176942000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	201031000	USD
CY2017	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	43461000	USD
CY2018	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	39102000	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	52582000	USD
CY2017	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	43461000	USD
CY2018	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	39102000	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	52582000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	177184000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	137840000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	148449000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	177184000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	137840000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	148449000	USD
CY2017	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	5758000	USD
CY2018	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	4551000	USD
CY2019	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	4995000	USD
CY2017	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	5751000	USD
CY2018	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	4548000	USD
CY2019	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	4994000	USD
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	171426000	USD
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	133289000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	143454000	USD
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	171433000	USD
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	133292000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	143455000	USD
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	171426000	USD
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	128955000	shares
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.33
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	171433000	USD
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	129126000	shares
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.33
CY2017	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	5758000	USD
CY2017	us-gaap	Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights	4332000	shares
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.33
CY2017	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	5751000	USD
CY2017	us-gaap	Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights	4332000	shares
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	133289000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	177184000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	177184000	USD
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	130172000	shares
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.02
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	133292000	USD
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	130256000	shares
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.02
CY2018	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	4551000	USD
CY2018	us-gaap	Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights	4444000	shares
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.02
CY2018	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	4548000	USD
CY2018	us-gaap	Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights	4444000	shares
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.02
CY2018	us-gaap	Net Income Loss NetIncomeLoss	137840000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	137840000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	143454000	USD
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	130248000	shares
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.10
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	143455000	USD
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	130276000	shares
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.10
CY2019	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	4995000	USD
CY2019	us-gaap	Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights	4535000	shares
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.10
CY2019	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	4994000	USD
CY2019	us-gaap	Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights	4535000	shares
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.10
CY2019	us-gaap	Net Income Loss NetIncomeLoss	148449000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	148449000	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1252964000	USD
CY2018Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1296210000	USD
CY2018Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1264683000	USD
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1267401000	USD
CY2018Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	1065813000	USD
CY2018Q2	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	1094731000	USD
CY2018Q3	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	1087062000	USD
CY2018Q4	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	1093450000	USD
CY2018Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	46771000	USD
CY2018Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	51724000	USD
CY2018Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	50527000	USD
CY2018Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	52633000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	108598000	USD
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	120561000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	99837000	USD
CY2018Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	88283000	USD
CY2018Q1	us-gaap	Profit Loss ProfitLoss	43982000	USD
CY2018Q2	us-gaap	Profit Loss ProfitLoss	60559000	USD
CY2018Q3	us-gaap	Profit Loss ProfitLoss	42679000	USD
CY2018Q4	us-gaap	Profit Loss ProfitLoss	29722000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	33739000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	46511000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	32917000	USD
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	24673000	USD
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.35
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.24
CY2018Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.18
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.25
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.24
CY2018Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1324631000	USD
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1361364000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1393343000	USD
CY2019Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1374584000	USD
CY2019Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	1132092000	USD
CY2019Q2	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	1150150000	USD
CY2019Q3	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	1183111000	USD
CY2019Q4	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	1175649000	USD
CY2019Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	52138000	USD
CY2019Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	54993000	USD
CY2019Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	52941000	USD
CY2019Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	52504000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	111724000	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	124882000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	122906000	USD
CY2019Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	112369000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	53344000	USD
CY2019Q2	us-gaap	Profit Loss ProfitLoss	59986000	USD
CY2019Q3	us-gaap	Profit Loss ProfitLoss	44030000	USD
CY2019Q4	us-gaap	Profit Loss ProfitLoss	43671000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	40834000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	44816000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	30732000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	32067000	USD
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.30
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.33
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.23
CY2019Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.24
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.30
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.33
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.23
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.24

Files In Submission

Name	View Source	Status
0001628280-20-001905-index-headers.html	Edgar Link	pending
0001628280-20-001905-index.html	Edgar Link	pending
0001628280-20-001905.txt	Edgar Link	pending
0001628280-20-001905-xbrl.zip	Edgar Link	pending
chart-340af19cb568523992b.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sem-12311910k.htm	Edgar Link	pending
sem-12311910kex211.htm	Edgar Link	pending
sem-12311910kex23.htm	Edgar Link	pending
sem-12311910kex311.htm	Edgar Link	pending
sem-12311910kex312.htm	Edgar Link	pending
sem-12311910kex321.htm	Edgar Link	pending
sem-12311910k_htm.xml	Edgar Link	completed
sem-123119xex43.htm	Edgar Link	pending
sem-20191231.xsd	Edgar Link	pending
sem-20191231_cal.xml	Edgar Link	unprocessable
sem-20191231_def.xml	Edgar Link	unprocessable
sem-20191231_lab.xml	Edgar Link	unprocessable
sem-20191231_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SEM
SELECT MEDICAL HOLDINGS CORP Stock $sem

2019 Form 10-K Financial Statement

#000162828020001905 Filed on February 20, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SEM SELECT MEDICAL HOLDINGS CORP Stock $sem

2019 Form 10-K Financial Statement

#000162828020001905 Filed on February 20, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SEM
SELECT MEDICAL HOLDINGS CORP Stock $sem